Paper34745261
m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment.
Liu F and 2 others. J Oncol, 2021. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment. Papers, record 34745261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34745261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer Microenvironment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28801472 | Breast Cancer Immunotherapy: Facts and Hopes. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/28801472 | PubMed |
| 2 | 28473315 | 4-1BB-Enhanced Expansion of CD8+ TIL from Triple-Negative Breast Cancer Unveils Mutation-Specific CD8+ T Cells. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28473315 | PubMed |
| 3 | 26320063 | Antagonists of PD-1 and PD-L1 in Cancer Treatment. | Semin Oncol | 2015 | https://conductscience.org/library/papers/26320063 | PubMed |
| 4 | 27808276 | Post-transcriptional gene regulation by mRNA modifications. | Nat Rev Mol Cell Biol | 2017 | https://conductscience.org/library/papers/27808276 | PubMed |
| 5 | 22326293 | Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers. | Eur J Cancer | 2012 | https://conductscience.org/library/papers/22326293 | PubMed |
| 6 | 31142332 | The role of m6A RNA methylation in human cancer. | Mol Cancer | 2019 | https://conductscience.org/library/papers/31142332 | PubMed |
| 7 | 32144194 | p53, cancer and the immune response. | J Cell Sci | 2020 | https://conductscience.org/library/papers/32144194 | PubMed |
| 8 | 27001847 | Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/27001847 | PubMed |
| 9 | 11994401 | Stat proteins and oncogenesis. | J Clin Invest | 2002 | https://conductscience.org/library/papers/11994401 | PubMed |
| 10 | 21388066 | Novel somatic frameshift mutations of genes related to cell cycle and DNA damage response in gastric and colorectal cancers with microsatellite instability. | Tumori | 2010 | https://conductscience.org/library/papers/21388066 | PubMed |
| 11 | 28256005 | Regulatory Role of N6 -methyladenosine (m6 A) Methylation in RNA Processing and Human Diseases. | J Cell Biochem | 2017 | https://conductscience.org/library/papers/28256005 | PubMed |
| 12 | 23593080 | STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer. | J Breast Cancer | 2013 | https://conductscience.org/library/papers/23593080 | PubMed |
| 13 | 32550918 | Macrophage correlates with immunophenotype and predicts anti-PD-L1 response of urothelial cancer. | Theranostics | 2020 | https://conductscience.org/library/papers/32550918 | PubMed |
| 14 | 20652980 | Prognostic significance of nuclear pSTAT3 in oral cancer. | Head Neck | 2011 | https://conductscience.org/library/papers/20652980 | PubMed |
| 15 | 25043940 | Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients. | Mol Carcinog | 2015 | https://conductscience.org/library/papers/25043940 | PubMed |
| 16 | 32067679 | Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer. | Ann Oncol | 2020 | https://conductscience.org/library/papers/32067679 | PubMed |
| 17 | 16478745 | Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. | J Natl Cancer Inst | 2006 | https://conductscience.org/library/papers/16478745 | PubMed |
| 18 | 30446007 | STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial. | J Immunother Cancer | 2018 | https://conductscience.org/library/papers/30446007 | PubMed |
| 19 | 27079802 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27079802 | PubMed |
| 20 | 31178748 | LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease. | Front Physiol | 2019 | https://conductscience.org/library/papers/31178748 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38410211 | Comprehensive analysis of m6A RNA methylation regulators in esophageal carcinoma. | Transl Cancer Res | 2024 | https://conductscience.org/library/papers/38410211 | PubMed |
| 37492716 | Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. | Genes Dis | 2023 | https://conductscience.org/library/papers/37492716 | PubMed |
| 37089261 | A Novel 7-Methylguanosine (m7G)-Related Gene Signature for Overall Survival Prediction in Patient with Clear Cell Renal Cell Carcinoma. | J Oncol | 2023 | https://conductscience.org/library/papers/37089261 | PubMed |
| 36685841 | Identification and experimental validation of key m6A modification regulators as potential biomarkers of osteoporosis. | Front Genet | 2022 | https://conductscience.org/library/papers/36685841 | PubMed |
| 36225914 | The regulation and potential roles of m6A modifications in early embryonic development and immune tolerance at the maternal-fetal interface. | Front Immunol | 2022 | https://conductscience.org/library/papers/36225914 | PubMed |
| 36142676 | Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142676 | PubMed |
| 36105819 | Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer. | Front Immunol | 2022 | https://conductscience.org/library/papers/36105819 | PubMed |
| 35780396 | m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/35780396 | PubMed |
| 35572541 | m6A Regulator-Mediated Tumour Infiltration and Methylation Modification in Cervical Cancer Microenvironment. | Front Immunol | 2022 | https://conductscience.org/library/papers/35572541 | PubMed |
| 35198565 | m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Cell-Infiltration Characterization in Head and Neck Cancer. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/35198565 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34745261
GET https://conductscience.org/api/papers/v1/34745261/references?page=2